Why your health plan doesn’t cover GLP-1s, according to a top insurance exec

Recent reports highlight an increase in Canadian employer-provided GLP-1 coverage, which has risen to 37% since 2024. Despite this growth, many individuals encounter significant hurdles when seeking insurance approval for weight-loss drugs.

Outlets including The Washington Post, Managed Healthcare Executive, and Pharmacy Times examine the disconnect between patient needs and payer policies. Coverage notes that some employers are actively directing staff toward cash-based platforms to obtain these medications, while pharmacists are increasingly positioned to assist patients in navigating complex access and affordability barriers.

Future developments remain dependent on how insurance providers adjust their formularies and how the use of direct-to-consumer cash platforms evolves. Coverage does not yet specify the long-term impact of these alternative access models on broader health plan structures.